Dr. Witowski has devoted his career to the study of bioactive and psychoactive medicines to benefit humanity and mental health. His research has received numerous accolades and patents on marketed products while bridging corporate leadership within emerging industries. He leads Psilera Bioscience, a psychedelic-based biotechnology company developing its proprietary neuromodulator pipeline to target cognitive, mood, and addiction disorders. Psilera leverages its research strengths and pharmaceutical background to repurpose psychoactive natural products as building blocks for next generation therapies to improve mental health.